Unity biotechnology, inc. (UBX)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Dec'16Dec'15
Beginning balance, (in shares)

-

-

0

0

0

0

-

-

-

-

-

-

Assets
Current assets:
Cash and cash equivalents

25,059

37,473

-

-

-

-

28,897

34,165

-

-

-

-

Short-term marketable securities

84,179

84,508

-

-

-

-

148,917

151,806

-

-

-

-

Strategic investment

4,120

5,507

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,875

1,999

-

-

-

-

2,002

1,650

-

-

-

-

Total current assets

115,233

129,487

-

-

-

-

179,816

187,621

-

-

-

-

Property and equipment, net

15,067

16,636

-

-

-

-

6,345

6,595

-

-

-

-

Operating lease right of use asset

25,443

-

-

-

-

-

-

-

-

-

-

-

Long-term marketable securities

-

3,025

-

-

-

-

6,386

12,073

-

-

-

-

Restricted cash

1,446

1,446

-

-

-

-

550

550

-

-

-

-

Other long-term assets

598

627

-

-

-

-

1,624

1,617

-

-

-

-

Total assets

157,787

151,221

-

-

-

-

194,721

208,456

-

-

-

-

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

4,015

5,185

-

-

-

-

2,624

1,883

-

-

-

-

Accrued compensation

2,222

5,905

-

-

-

-

2,839

1,941

-

-

-

-

Accrued and other current liabilities

7,422

4,995

-

-

-

-

4,618

4,856

-

-

-

-

Contingent consideration liability

910

1,131

-

-

-

-

1,609

725

-

-

-

-

Total current liabilities

14,569

17,216

-

-

-

-

11,690

9,405

-

-

-

-

Operating lease liability, net of current portion

37,889

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, net of current portion

-

13,298

-

-

-

-

2,667

2,867

-

-

-

-

Contingent consideration liability, net of current portion

-

-

-

-

-

-

784

1,033

-

-

-

-

Other non-current liabilities

-

-

-

-

-

-

64

82

-

-

-

-

Total liabilities

52,458

30,514

-

-

-

-

15,205

13,387

-

-

-

-

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

0

-

-

-

-

Stockholders’ equity:
Convertible preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding

0

0

-

-

-

-

-

-

-

-

-

-

Common stock, $0.0001 par value; 300,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 48,857,504 and 47,227,065 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

5

5

-

-

-

-

4

4

-

-

-

-

Additional paid-in capital

379,072

366,695

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

321,594

318,758

-

-

-

-

Related party promissory notes for purchase of common stock

210

210

-

-

-

-

201

201

-

-

-

-

Employee promissory notes for purchase of common stock

418

418

-

-

-

-

400

400

-

-

-

-

Accumulated other comprehensive income

373

90

-

-

-

-

-119

-77

-

-

-

-

Accumulated deficit

-273,493

-245,455

-

-

-

-

-141,362

-123,015

-

-

-

-

Total stockholders’ equity

105,329

120,707

114,717

127,050

146,603

160,693

179,516

195,069

-98,631

-83,113

-41,536

-11,745

Beginning balance, (in shares)

-

-

44,088

43,203

42,888

42,414

-

-

-

-

-

-

Ending balance

105,329

120,707

114,717

127,050

146,603

160,693

-

-

-98,631

-83,113

-41,536

-11,745

Ending balance, (in shares)

-

-

0

0

0

0

-

-

-

-

-

-

Ending balance (in shares)

-

-

44,088

43,203

42,888

42,414

-

-

-

-

-

-

Total liabilities and stockholders’ equity

157,787

151,221

-

-

-

-

194,721

208,456

-

-

-

-

Convertible Preferred Stock
Beginning balance, (in shares)

-

-

0

0

0

0

-

-

31,750

28,159

24,620

8,713

Beginning balance

-

-

-

-

-

-

-

-

228,906

173,956

131,089

7,579

Ending balance, (in shares)

-

-

0

0

0

0

-

-

31,750

28,159

24,620

8,713

Ending balance

-

-

-

-

-

-

-

-

228,906

173,956

131,089

7,579

Common Stock
Beginning balance

-

-

4

4

4

4

-

-

1

1

1

1

Beginning balance, (in shares)

-

-

44,088

43,203

42,888

42,414

-

-

5,230

4,830

4,303

2,054

Ending balance

-

-

4

4

4

4

-

-

1

1

1

1

Ending balance (in shares)

-

-

44,088

43,203

42,888

42,414

-

-

5,230

4,830

4,303

2,054

Additional Paid-In Capital
Beginning balance

-

-

342,647

333,252

329,226

324,663

-

-

5,511

4,072

889

123

Ending balance

-

-

342,647

333,252

329,226

324,663

-

-

5,511

4,072

889

123

Related Party Promissory Notes for Purchase of Commmon Stock
Beginning balance

-

-

-201

-

-

-201

-

-

-592

-202

-202

-

Beginning balance

-

-

-

-201

-201

-

-

-

-

-

-

-49

Ending balance

-

-

-201

-

-

-201

-

-

-592

-202

-202

-

Ending balance

-

-

-

-201

-201

-

-

-

-

-

-

-49

Employee Promissory Notes for Purchase of Commmon Stock
Beginning balance

-

-

-400

-400

-400

-400

-

-

-400

-

-

-

Ending balance

-

-

-400

-400

-400

-400

-

-

-400

-

-

-

Accumulated Other Comprehensive Loss
Beginning balance

-

-

95

113

19

-95

-

-

-138

-104

-

-

Ending balance

-

-

95

113

19

-95

-

-

-138

-104

-

-

Accumulated Deficit
Beginning balance

-

-

-227,428

-205,718

-182,045

-163,278

-

-

-103,013

-86,880

-42,224

-11,820

Ending balance

-

-

-227,428

-205,718

-182,045

-163,278

-

-

-103,013

-86,880

-42,224

-11,820